免费日韩片_欧美成人精品一区二区男人小说_国产乱码一区二区三区四区_国产精品国产三级国产aⅴ入口_成人看的污污超级黄网站免费_欧美一级在线免费观看_成人午夜免费无码福利片_国产乱人伦偷精品视频色欲_aaa少妇高潮大片免费看_国产精品1234_亚洲精品国产suv一区88_中文字字幕在线中文无码_精品亚洲区_午夜九九九_国产av国片精品jk制服丝袜_色综合亚洲_亚洲成av人片无码bt种子下载_欧美色就色_精品少妇的一区二区三区四区_男人用嘴添女人下身免费视频

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Bayer, medical body sign deal to boost innovation in public hospitals

By ZHENG YIRAN | chinadaily.com.cn | Updated: 2021-09-05 13:22
Share
Share - WeChat
A booth of Bayer AG at the ongoing China International Fair for Trade in Services in Beijing. [Photo provided to chinadaily.com.cn]

German pharmaceutical giant Bayer AG signed a deal with the Beijing branch of the Chinese Medical Association on a research-based hospital room project to promote the innovative development of Chinese public hospitals.

The two parties signed an agreement during the ongoing China International Fair for Trade in Services. According to the agreement, they will jointly launch a research project to promote the construction of research-based patient rooms in Beijing.

A research patient room is a place where medical workers conduct clinical research on drugs and medical devices, and observe the clinical application of new biomedical technologies in hospitals with conditions. It is an important medical resource and technological infrastructure.

The research project takes public hospitals that have already begun research-based ward construction as the research object, sorts out and analyzes the implementation status of research and construction, summarizes the typical experience of pilot hospitals, and further explores new models of research-based ward construction.

Feng Guosheng, head of the Beijing branch of the Chinese Medical Association, said: "The improvement of medical system is closely related to medical scientific research. This research project, which is under the guidance of Beijing Municipal Health Commission and Beijing Municipal Science & Technology Commission, is beneficial to improving hospitals' clinical research quality, strengthening their innovative abilities, and promoting the construction of research-based patient rooms."

"Our cooperation with Bayer is an effective attempt of joining efforts from academic institutions and enterprises to promote innovative clinical research," he said.

This year's CIFTIS has included the theme of healthcare service for the first time. Currently, the world is facing huge public health challenges, and medical and health-related topics have attracted great attention.

According to Bayer, during this year's CIFTIS, it will demonstrate its innovative drugs in diabetes, cardiovascular diseases and cancer.

Zhou Xiaolan, executive vice-president & president of Bayer Pharmaceuticals China, said: "The CIFTIS is an important window for China's opening-up. It offers an international platform for multinational corporations, such as Bayer, to present themselves and cooperate with other parties. It is also a crucial channel for us to learn more about local medical needs."

"Taking advantage of the fair, Bayer hope to deepen the communication and cooperation with our Chinese partners, give full play to our advantage in healthcare, constantly bring more innovative products to Chinese patients, and contribute to the implementation of crucial national strategies such as 'Healthy China'," she said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE